Standard Dose Versus High-Dose Inactivated Flu Vaccine in Pediatric Solid Organ Transplant Patients
Status:
Completed
Trial end date:
2012-12-01
Target enrollment:
Participant gender:
Summary
This is a phase I trial in which the both the safety and immunogenicity of the standard dose
flu vaccine will be compared with high dose flu vaccine in children that have undergone solid
organ transplantation (SOT).
Phase:
Phase 1
Details
Lead Sponsor:
Vanderbilt University
Collaborators:
MCM Vaccines B.V. Sanofi Pasteur MSD University of Pittsburgh